Embed

Academic

Authors

Rolando Vallansot

Rolando Vallansot,Universitat de Barcelona,Oncology,Cell Biology

Edit

Rolando Vallansot

Universitat de Barcelona

Publications: 6 | Citations: 13

Fields: Oncology, Cell Biology

Collaborated with 26 co-authors from 2006 to 2011 | Cited by 41 authors

Cumulative Annual

Sort by:

Publications (6)

BibTeX | RIS | RefWorks Download

Correlation between genetic polymorphisms of the hOCT1 and MDR1 genes and the response to imatinib in patients newly diagnosed with chronic-phase chronic myeloid leukemia (Citations: 1)

, , , , , , , , , , , http://academic.research.microsoft.com/io.ashx?type=5&id=49183591&selfId1=21579562&selfId2=0&maxNumber=12&query=

Journal: Leukemia Research - LEUK RES , vol. 35, no. 8, pp. 1014-1019, 2011

Increased Serum Tumor Markers (CA125 and CA15.3) in Primary Plasma Cell Leukemia: A Case Report and Review of the Literature

, , , ,

Journal: Clinical Lymphoma & Myeloma , vol. 8, no. 5, pp. 312-314, 2008

Conventional and New Treatment Modalities in Myelofibrosis and the Current Role of Transplantation

, , ,

Journal: Clinical Leukemia , vol. 2, no. 1, pp. 39-45, 2008

Hepatitis tóxica por imatinib: descripción de dos casos y revisión de la literatura médica (Citations: 1)

, , , ,

Published in 2007.

Trasplante autólogo de progenitores hematopoyéticos en el síndrome de POEMS: resultados en 4 casos (Citations: 1)

, , , , , , ,

Journal: Medicina Clinica - MED CLIN , vol. 129, no. 15, pp. 578-581, 2007

Sort by:

Citations (13 times by 13 publications)

Imatinib mesylate-induced acute liver failure in a patient with gastrointestinal stromal tumors (Citations: 1)

, , , , , , ,

Journal: Medical Oncology - MED ONCOL , vol. 27, no. 3, pp. 768-773, 2010

Efficacy and tolerability of hydroxyurea in the treatment of the hyperproliferative manifestations of myelofibrosis: results in 40 patients (Citations: 3)

, , , , , ,

Journal: Annals of Hematology - ANN HEMATOL , vol. 89, no. 12, pp. 1233-1237, 2010

Essential thrombocythemia, polycythemia vera, and myelofibrosis: Current management and the prospect of targeted therapy (Citations: 28)

Journal: American Journal of Hematology - AMER J HEMATOL , vol. 83, no. 6, pp. 491-497, 2008

Choosing between stem cell therapy and drugs in myelofibrosis (Citations: 23)

Journal: Leukemia , vol. 22, no. 3, pp. 474-486, 2008

A case of POEMS syndrome treated by autologous hematopoietic stem-cell transplantation (Citations: 1)

, , , , , ,

Journal: Nature Clinical Practice Neurology - NAT CLIN PRACT NEUROL , vol. 4, no. 12, pp. 686-691, 2008

Comments

Co-authors (26)

Journals (5)

Keywords (10)

Rolando Vallansot,Universitat de Barcelona,Oncology,Cell Biology

Publications (6)

BibTeX | RIS | RefWorks Download

Correlation between genetic polymorphisms of the hOCT1 and MDR1 genes and the response to imatinib in patients newly diagnosed with chronic-phase chronic myeloid leukemia (Citations: 1)

Increased Serum Tumor Markers (CA125 and CA15.3) in Primary Plasma Cell Leukemia: A Case Report and Review of the Literature

Conventional and New Treatment Modalities in Myelofibrosis and the Current Role of Transplantation

Hepatitis tóxica por imatinib: descripción de dos casos y revisión de la literatura médica (Citations: 1)

Trasplante autólogo de progenitores hematopoyéticos en el síndrome de POEMS: resultados en 4 casos (Citations: 1)

Citations (13 times by 13 publications)

Imatinib mesylate-induced acute liver failure in a patient with gastrointestinal stromal tumors (Citations: 1)

Efficacy and tolerability of hydroxyurea in the treatment of the hyperproliferative manifestations of myelofibrosis: results in 40 patients (Citations: 3)

Essential thrombocythemia, polycythemia vera, and myelofibrosis: Current management and the prospect of targeted therapy (Citations: 28)

Choosing between stem cell therapy and drugs in myelofibrosis (Citations: 23)

A case of POEMS syndrome treated by autologous hematopoietic stem-cell transplantation (Citations: 1)


	View FAQ about top research areas and Fields of study

Co-authors (26)

Journals (5)

Keywords (10)

Rolando Vallansot,Universitat de Barcelona,Oncology,Cell Biology

Publications (6) BibTeX | RIS | RefWorks Download

Correlation between genetic polymorphisms of the hOCT1 and MDR1 genes and the response to imatinib in patients newly diagnosed with chronic-phase chronic myeloid leukemia (Citations: 1)

Increased Serum Tumor Markers (CA125 and CA15.3) in Primary Plasma Cell Leukemia: A Case Report and Review of the Literature

Conventional and New Treatment Modalities in Myelofibrosis and the Current Role of Transplantation

Hepatitis tóxica por imatinib: descripción de dos casos y revisión de la literatura médica (Citations: 1)

Trasplante autólogo de progenitores hematopoyéticos en el síndrome de POEMS: resultados en 4 casos (Citations: 1)

Citations (13 times by 13 publications)

Imatinib mesylate-induced acute liver failure in a patient with gastrointestinal stromal tumors (Citations: 1)

Efficacy and tolerability of hydroxyurea in the treatment of the hyperproliferative manifestations of myelofibrosis: results in 40 patients (Citations: 3)

Essential thrombocythemia, polycythemia vera, and myelofibrosis: Current management and the prospect of targeted therapy (Citations: 28)

Choosing between stem cell therapy and drugs in myelofibrosis (Citations: 23)

A case of POEMS syndrome treated by autologous hematopoietic stem-cell transplantation (Citations: 1)

Publications (6)

BibTeX | RIS | RefWorks Download